Skip to main content

AbbVie, Allergen sign deal with FTC to preserve merger plans

By MarketWatch  
   March 18, 2020

AbbVie Inc. and Allergan PLC announced Tuesday that they signed a consent decree with the U.S. Federal Trade Commission that will commit the companies to selling some properties if they commence a planned merger.

Full story

Get the latest on healthcare leadership in your inbox.